Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 173 | 169 | 148 | 142 | 109 |
| Gross Profit | 173 | 169 | 148 | 142 | 109 |
| Operating Expenses | 13,399 | 20,686 | 17,565 | 18,329 | 12,138 |
| Operating Income | -13,226 | -20,517 | -17,417 | -18,188 | -12,029 |
| Other Income | -780 | 29,038 | 5,723 | 2,866 | 776 |
| Pre-tax Income | -14,006 | 8,521 | -11,694 | -15,322 | -11,253 |
| Net Income Continuous | -14,006 | 8,521 | -11,694 | -15,322 | -11,253 |
| Net Income | $-14,006 | $8,521 | $-11,694 | $-15,322 | $-11,253 |
| EPS Basic Total Ops | -0.20 | 0.12 | -0.17 | -0.20 | -0.16 |
| EPS Basic Continuous Ops | -0.20 | 0.12 | -0.17 | -0.22 | -0.16 |
| EPS Diluted Total Ops | -0.20 | 0.12 | -0.17 | -0.20 | -0.16 |
| EPS Diluted Continuous Ops | -0.20 | 0.12 | -0.17 | -0.22 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.20 | 0.12 | -0.17 | N/A | N/A |
| EBITDA(a) | $-13,057 | $-20,369 | $-17,281 | $-18,047 | $-11,883 |